Page last updated: 2024-08-24

norharman and beta-lapachone

norharman has been researched along with beta-lapachone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Bian, J; Feng, X; Li, Z; Liao, D; Liu, D; Ping, A1

Reviews

1 review(s) available for norharman and beta-lapachone

ArticleYear
Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective.
    Journal of medicinal chemistry, 2020, 12-24, Volume: 63, Issue:24

    Topics: Binding Sites; Catalytic Domain; Drug Discovery; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Indoles; Molecular Docking Simulation; Neoplasms; Small Molecule Libraries

2020

Other Studies

1 other study(ies) available for norharman and beta-lapachone

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012